Početna › Crohnova bolest › Florida
Kliničke studije za Crohnova bolest u državi Florida
27 studija za Crohnova bolest traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
- Miami19 studija
- Orlando17 studija
- Tampa10 studija
- Kendall5 studija
- Jacksonville4 studija
- Hialeah4 studija
- Spring Hill4 studija
- Gainesville3 studija
- Pensacola3 studija
- Town 'n' Country3 studija
- Clearwater3 studija
- Lakeland3 studija
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
- Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
- Sanchez Clinical Research ( Site 5144), Miami
- i još 4
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- i još 5
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Novum Research /ID# 278128, Clermont
- University of Florida College of Medicine /ID# 266930, Gainesville
- Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
- i još 9
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Green Leaf Clinical Trials, Jacksonville
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Center Inc., Lakewood Rch
- i još 2
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- Wellness Clinical Research, Miami Lakes
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- i još 3
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
- University of Miami, Miami
U tijeku regrutacija
Od 16 do 75 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07671872An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Novum Research, LLC-Site Number: 8400003, Clermont
- Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- i još 12
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
- i još 2
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Bioresearch Partner-Kendale Lakes, Miami
- Endoscopic Research Inc, Orlando
- i još 1
U tijeku regrutacijaFaza 2
Od 18 do 85 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
U tijeku regrutacijaFaza 4
Od 18 do 70 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07577843Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07237516Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- Digestive & Liver Center of Florida, Orlando
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 16. srp 2026. · NCT06997965Precise Infliximab Exposure and Pharmacodynamic Control
- Nemours Children's Health System-Jacksonville, Jacksonville
U tijeku regrutacijaFaza 2/3
Od 6 do 22 godina · Oba spola · Ažurirano 5. svi 2026. · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Clinical Research Of Brandon, LLC, Brandon
- West Central Gastroenterology d/b/a Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- i još 7
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 27. tra 2026. · NCT06456593Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- University of Miami, Miami
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 30. ožu 2026. · NCT06774079A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400017, Kissimmee
- Investigational Site Number: 8400015, Lighthouse PT
- Investigational Site Number 8400028, Miami
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 27. ožu 2026. · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07113522A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacija
Od 18 do 70 godina · Oba spola · Ažurirano 17. velj 2026. · NCT06647615Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Florida, Gainesville
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 10. pro 2025. · NCT06721962Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.